826 related articles for article (PubMed ID: 14677084)
1. Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms.
Bschor T; Lewitzka U; Sasse J; Adli M; Köberle U; Bauer M
Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S230-4. PubMed ID: 14677084
[TBL] [Abstract][Full Text] [Related]
2. Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression.
Bschor T; Baethge C; Adli M; Eichmann U; Ising M; Uhr M; Müller-Oerlinghausen B; Bauer M
Depress Anxiety; 2003; 17(1):43-8. PubMed ID: 12577277
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcome after lithium augmentation in unipolar depression: focus on HPA system activity.
Adli M; Bschor T; Bauer M; Lucka C; Lewitzka U; Ising M; Uhr M; Mueller-Oerlinghausen B; Baethge C
Neuropsychobiology; 2009; 60(1):23-30. PubMed ID: 19684420
[TBL] [Abstract][Full Text] [Related]
4. Lithium's emerging role in the treatment of refractory major depressive episodes: augmentation of antidepressants.
Bauer M; Adli M; Bschor T; Pilhatsch M; Pfennig A; Sasse J; Schmid R; Lewitzka U
Neuropsychobiology; 2010; 62(1):36-42. PubMed ID: 20453533
[TBL] [Abstract][Full Text] [Related]
5. Lithium, arginine vasopressin and the dex/CRH test in mood disordered patients.
Watson S; Gallagher P; Smith MS; Young AH; Ferrier IN
Psychoneuroendocrinology; 2007 Jun; 32(5):464-9. PubMed ID: 17442500
[TBL] [Abstract][Full Text] [Related]
6. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
Künzel HE; Ackl N; Hatzinger M; Held K; Holsboer-Trachsler E; Ising M; Kaschka W; Kasper S; Konstantinidis A; Sonntag A; Uhr M; Yassouridis A; Holsboer F; Steiger A
J Psychiatr Res; 2009 Apr; 43(7):702-10. PubMed ID: 19038406
[TBL] [Abstract][Full Text] [Related]
7. Lithium augmentation therapy in refractory depression: clinical evidence and neurobiological mechanisms.
Bauer M; Adli M; Baethge C; Berghöfer A; Sasse J; Heinz A; Bschor T
Can J Psychiatry; 2003 Aug; 48(7):440-8. PubMed ID: 12971013
[TBL] [Abstract][Full Text] [Related]
8. Lithium augmentation increases the ACTH and cortisol response in the combined DEX/CRH test in unipolar major depression.
Bschor T; Adli M; Baethge C; Eichmann U; Ising M; Uhr M; Modell S; Künzel H; Müller-Oerlinghausen B; Bauer M
Neuropsychopharmacology; 2002 Sep; 27(3):470-8. PubMed ID: 12225704
[TBL] [Abstract][Full Text] [Related]
9. Treatment of depression in bipolar disorder: new directions for research.
Zornberg GL; Pope HG
J Clin Psychopharmacol; 1993 Dec; 13(6):397-408. PubMed ID: 8120153
[TBL] [Abstract][Full Text] [Related]
10. [Lithium in the treatment of acute depression].
Adli M; Bschor T; Canata B; Döpfmer S; Bauer M
Fortschr Neurol Psychiatr; 1998 Oct; 66(10):435-41. PubMed ID: 9825248
[TBL] [Abstract][Full Text] [Related]
11. Lithium combinations in acute and maintenance treatment of unipolar and bipolar depression.
Fawcett JA
J Clin Psychiatry; 2003; 64 Suppl 5():32-7. PubMed ID: 12720482
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and mechanisms of action of lithium augmentation in refractory major depression.
Bschor T; Bauer M
Curr Pharm Des; 2006; 12(23):2985-92. PubMed ID: 16918427
[TBL] [Abstract][Full Text] [Related]
13. The use of lithium to augment antidepressant medication.
Rouillon F; Gorwood P
J Clin Psychiatry; 1998; 59 Suppl 5():32-9; discussion 40-1. PubMed ID: 9635546
[TBL] [Abstract][Full Text] [Related]
14. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
Binder EB; Künzel HE; Nickel T; Kern N; Pfennig A; Majer M; Uhr M; Ising M; Holsboer F
Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrinological mechanisms of actions of antidepressant drugs.
Schüle C
J Neuroendocrinol; 2007 Mar; 19(3):213-26. PubMed ID: 17280595
[TBL] [Abstract][Full Text] [Related]
16. [Combination therapies in antidepressive drug refractory depression--an overview].
Schmauss M; Erfurth A
Fortschr Neurol Psychiatr; 1996 Oct; 64(10):390-402. PubMed ID: 9036099
[TBL] [Abstract][Full Text] [Related]
17. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
[TBL] [Abstract][Full Text] [Related]
18. The dexamethasone suppression test and response to somatic treatment: a review.
Gitlin MJ; Gerner RH
J Clin Psychiatry; 1986 Jan; 47(1):16-21. PubMed ID: 3510195
[TBL] [Abstract][Full Text] [Related]
19. Augmentation strategies for treatment-resistant depression.
Carvalho AF; Machado JR; Cavalcante JL
Curr Opin Psychiatry; 2009 Jan; 22(1):7-12. PubMed ID: 19122528
[TBL] [Abstract][Full Text] [Related]
20. Lithium augmentation therapy in refractory depression-update 2002.
Bauer M; Forsthoff A; Baethge C; Adli M; Berghöfer A; Döpfmer S; Bschor T
Eur Arch Psychiatry Clin Neurosci; 2003 Jun; 253(3):132-9. PubMed ID: 12904977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
